- Home
- FLL vs GLSI Comparison
FLL vs GLSI Comparison
Compare FLL & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLL
- GLSI
- Stock Information
- Founded
- FLL 1987
- GLSI 2006
- Country
- FLL United States
- GLSI United States
- Employees
- FLL N/A
- GLSI N/A
- Industry
- FLL Hotels/Resorts
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- FLL Consumer Discretionary
- GLSI Health Care
- Exchange
- FLL Nasdaq
- GLSI Nasdaq
- Market Cap
- FLL 108.7M
- GLSI 108.8M
- IPO Year
- FLL 1993
- GLSI 2020
- Fundamental
- Price
- FLL $2.63
- GLSI $8.42
- Analyst Decision
- FLL Buy
- GLSI Strong Buy
- Analyst Count
- FLL 4
- GLSI 1
- Target Price
- FLL $5.00
- GLSI $39.00
- AVG Volume (30 Days)
- FLL 195.1K
- GLSI 84.7K
- Earning Date
- FLL 11-06-2025
- GLSI 11-14-2025
- Dividend Yield
- FLL N/A
- GLSI N/A
- EPS Growth
- FLL N/A
- GLSI N/A
- EPS
- FLL N/A
- GLSI N/A
- Revenue
- FLL $299,916,000.00
- GLSI N/A
- Revenue This Year
- FLL $4.96
- GLSI N/A
- Revenue Next Year
- FLL $8.15
- GLSI N/A
- P/E Ratio
- FLL N/A
- GLSI N/A
- Revenue Growth
- FLL 7.45
- GLSI N/A
- 52 Week Low
- FLL $2.25
- GLSI $7.78
- 52 Week High
- FLL $5.59
- GLSI $15.47
- Technical
- Relative Strength Index (RSI)
- FLL 53.79
- GLSI 43.03
- Support Level
- FLL $2.25
- GLSI $7.78
- Resistance Level
- FLL $2.74
- GLSI $8.53
- Average True Range (ATR)
- FLL 0.18
- GLSI 0.51
- MACD
- FLL 0.04
- GLSI 0.08
- Stochastic Oscillator
- FLL 75.70
- GLSI 43.02
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.